New shot takes aim at stubborn genetic cholesterol
NCT ID NCT07591298
First seen May 25, 2026 · Last updated May 25, 2026
Summary
This study tests an experimental injection called SYH2070 in 18 adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. The main goal is to see how much the drug lowers LDL (bad) cholesterol. Participants must already be on stable cholesterol-lowering treatment and will receive the injection on top of their usual care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIAGNOSED WITH HOFH are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.